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muscle, the correlation between blood flow, symptoms, and
exercise ability is poor,2 which might reflect either helpful
metabolic adaptation or an acquired myopathy,1 perhaps
caused by oxidative stress.3 These questions are difficult,
although not impossible,4-6 to study with invasive methods.
Two useful noninvasive methods are 31P magnetic reso-
nance spectroscopy (31P MRS), which is a means of mea-
suring aspects of adenosine triphosphate (ATP) turnover,7-9
and near-infrared spectroscopy (NIRS), which is a means of
measuring muscle oxygenation.10 Both 31P MRS8,11-16 and
NIRS17-19 have shown muscle abnormalities in PVD. We
set out to make both measurements simultaneously, to clar-
ify the pathophysiology and thereby develop a method for
assessing possible treatment mechanisms.
METHODS
Subjects
We observed 11 male patients with PVD and nine male
control subjects (Table I). Inclusion criteria included 6
months’ or more intermittent calf claudication with proven
femoropopliteal or iliofemoral occlusive or stenotic disease;
MWD less than 230 m (2 km/h, 10° gradient); and an
In peripheral vascular disease (PVD), morbidity result-
ing from claudication is relatively common and not easy to
treat.1 The objective assessment of impaired muscle func-
tion is difficult, with the most practical method being the
maximum treadmill walking distance (MWD). Although
the basic cause is insufficient blood supply to exercising
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Purpose: We used 31P magnetic resonance spectroscopy (MRS) and near-infrared spectroscopy (NIRS) as a means of
quantifying abnormalities in calf muscle oxygenation and adenosine triphosphate (ATP) turnover in peripheral vascu-
lar disease (PVD).
Methods: Eleven male patients with PVD (mean age, 65 years; range, 55-76 years) and nine male control subjects of sim-
ilar age were observed in a case-control study in vascular outpatients. Inclusion criteria were more than 6 months’ calf
claudication (median, 1.5 years; range, 0.6-18 years); proven femoropopliteal or iliofemoral occlusive or stenotic dis-
ease; maximum treadmill walking distance (2 km/h, 10° gradient) of 50 to 230 m (mean, 112 m); ankle-brachial pres-
sure index of 0.8 or less during exercise (mean, 0.47; range, 0.29-0.60). Exclusion criteria included diabetes mellitus,
anemia, and magnet contraindications.
Simultaneous 31P MRS and NIRS of lateral gastrocnemius was conducted during 2 to 4 minutes of voluntary 0.5 Hz
isometric plantarflexion at 50% and 75% maximum voluntary contraction force (MVC), followed by 5 minutes recov-
ery. Each subject was studied three times, and the results were combined.
Results: Compared with control subjects, patients with PVD showed (1) normal muscle cross-sectional area, MVC, ATP
turnover, and contractile efficiency (ATP turnover per force/area); (2) larger phosphocreatine (PCr) changes during
exercise (ie, increased shortfall of oxidative ATP synthesis) and slower PCr recovery (47% ± 7% [mean ± SEM] decrease
in functional capacity for oxidative ATP synthesis, P = .001); (3) faster deoxygenation during exercise and slower pos-
texercise reoxygenation (59% ± 7% decrease in rate constant, P =.0009), despite reduced oxidative ATP synthesis; (4)
correlation between PCr and NIRS recovery rate constants (P < .02); and (5) correlations between smaller walking dis-
tance, slower PCr recovery, and reduced MVC (P < .001). The precision of the key measurements (rate constants and
contractile efficiency) was 12% to 18% interstudy and 30% to 40% intersubject.
Conclusion: The primary lesion in oxygen supply dominates muscle metabolism. Reduced force-generation in patients
who are affected more may protect muscle from metabolic stress. (J Vasc Surg 2001;34:1103-10.)
ankle-brachial pressure index of 0.8 or less (rest or exer-
cise). Exclusion criteria were diabetes mellitus, anemia, or
magnet contraindications. Each subject gave fully informed
written consent, and the work was conducted with the
approval of the Liverpool Research Ethics Committee, in
accordance with the Declaration of Helsinki of the World
Medical Association. Subjects were forbidden from smok-
ing for 2 hours before each study. Each subject was studied
on three occasions within 1 to 12 weeks (median, 5 weeks).
Magnetic resonance methods
In a Signa Advantage 1.5 tesla whole body MR system
(General Electric, Milwaukee, Wis), subjects lay supine on
a rig permitting isometric plantarflexion. Force measured
by means of a strain gauge was fed back through a light-
emitting diode display. Maximum voluntary force (MVC)
was measured (in voltage units) three times before each
study. An axial T2-weighted spin echo image was obtained
for measuring cross-sectional area. 31P MRS data were
acquired with a 10- by 6-cm elliptical RF surface coil over
the right lateral belly of the gastrocnemius. NIRS data
were acquired simultaneously from the same site with a
Runman CES-2000 instrument (NIM, Philadelphia, Pa)
with fiberoptic light guides passing through the RF coil.
After B0 field homogeneity was optimized by manually
shimming on a water signal, 31P spectra were obtained
with 2 second repetition time at rest (128 scans) and then
throughout an exercise/recovery protocol (8-scan spec-
tra). Exercise was audibly cued voluntary 0.5 Hz isomet-
ric plantarflexion with 50:50 duty cycle. The protocol
comprised 3 spectra at rest, 12 spectra during exercise at
50% MVC (3.2 minutes), followed by 20 recovery spectra
(5.3 minutes); then 8 spectra during exercise at 75% MVC
(2.1 minutes) followed by 20 recovery spectra (5.3 min-
utes); the second (75% MVC) exercise/recovery was then
repeated. If exercise ended early because of the patient’s
fatigue or pain, recovery collection started early, but the
next exercise started at the normal time.
Data acquisition and processing
Force and NIRS data were captured through a
PowerLab ADI on a personal computer running Chart
software (ADInstruments, Hastings, UK). The NIRS sig-
nal (digitized manually in the Chart software) represents
the difference in absorption at two wavelengths, propor-
tional to deoxygenated hemoglobin content.10 Because
the scaling factor varies unpredictably between studies,
absolute changes were expressed relative to the difference
between the extreme signals at the two wavelengths, so
that deoxyhemoglobin content is in arbitrary units, but
independent of instrument gain. (Scaling to maximum sig-
nal change in exhaustive ischemic exercise10 was not toler-
ated by many subjects.)
The maximum cross-sectional area of the posterior calf
(ie, soleus plus gastrocnemius) was measured by means of
point-counting20 with ANALYZE software (Mayo
Foundation, Rochester, Minn). 31P MRS data were ana-
lyzed with Magnetic Resonance User Interface software
(MRUI 97.1), which implements the AMARES time-
domain fitting algorithm. Resting spectra were fitted with
10 Lorentzian peaks: Pi, phosphodiester, phosphocreatine
(PCr), 2 peaks (amplitude ratio 1:1) each for γ-ATP and
α-ATP and 3 (amplitude ratio 1:2:1) for β-ATP. Exercise
spectra were fitted with three Lorentzian peaks: Pi, PCr,
and ATP (no significant changes in ATP were observed).
Cell pH was obtained from the chemical shift of Pi relative
to PCr21. Changes in PCr and derived quantities were
expressed relative to resting PCr concentration to avoid
problems of absolute quantification.
Data analysis
Background. In exercising muscle, the myosin
adenosine triphosphatase (ATPase) does mechanical work
with ATP generated either by glycolysis to lactate or
(more efficiently) by full oxidation to CO2; the creatine
kinase equilibrium ensures that any ATP shortfall is met by
net “splitting” of PCr22. In the current experiments, ATP
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Table I. Characteristics of patients and control subjects
Control subjects Patients with PVD
Mean ± SD Range Mean ± SD Range
Age (y) 58 ± 7 51-71 65 ± 8 55-76
Median duration of symptoms (y) — — 1.5 0.6-18.0
Body weight (kg) 81 ± 13 61-96 78 ± 15 57-108
Body mass index (kg/cm2) 26 ± 5 19-32 16 ± 4 20-31
Systolic blood pressure (mm Hg) 130 ± 16 109-160 154 ± 26 130-190
Diastolic blood pressure (mm Hg) 81 ± 11 60-95 85 ± 18 60-120
MWD (m) — — 112 ± 62 53-230
Rest ABPI — — 0.73 ± 0.18 0.35-1.00
Exercise ABPI — — 0.47 ± 0.10 0.29-0.60
Systolic blood pressure was 24 mm Hg higher, on average, in the patients (P = .02). Four patients and 1 control subject were taking antihypertensive med-
ication; 6 control subjects and 10 patients were smokers or ex-smokers.
ABPI, Ankle brachial pressure index; MWD, maximum walking distance; PVD, peripheral vascular disease.
synthesis is largely oxidative (see the “Results” section),
which simplifies the following explanation. At the start of
exercise, ATP is supplied only by PCr splitting; then as
oxidative ATP production increases, PCr concentration
stabilizes.7 At the same time, deoxyhemoglobin increases
as oxygen consumption exceeds vascular oxygen supply
and may also reach steady state. When exercise ceases, PCr
recovers at the expense of oxidative ATP synthesis;
because mitochondrial oxygen use declines faster than vas-
cular oxygen supply, deoxyhemoglobin decreases.
Measuring overall shortfall in ATP production.
The average rate of PCr change during exercise, the total
PCr change (–∆[PCr]) divided by exercise duration (∆t),
is a measure of the all-exercise average failure of oxidative
ATP synthesis (strictly, oxidative plus glycolytic) to meet
ATP demand.23 In pathophysiologic terms, –∆[PCr]/∆t
will increase (ie, PCr change will increase, duration will
decrease, or both) either because ATP demand is increased
or because oxidative ATP supply is impaired.
Measuring ATP demand. The initial rate of fall of PCr
in exercise (–d[PCr]/dt) is a measure of ATP turnover
rate.9,24 This measure divided by force output per unit cross-
sectional area is a measure of contractile efficiency (recipro-
cal of contractile cost9), which measures how well ATP is
used to generate force; this is a function of fiber type25 and
exercise mechanism.26-28 –d[PCr]/dt was calculated from a
least-squares monoexponential fit of PCr against time. When
fitted without constraints, the rates at 75% MVC and 50%
MVC were linear with power, as expected29-31; so to
improve precision, we refitted the data with this as a con-
straint and reported the rate for 50% MVC.
Measuring oxidative ATP synthesis. The initial-
recovery rate of PCr resynthesis (d[PCr]/dt, calculated
from a monoexponential fit) is an estimate of the end-
exercise rate of oxidative ATP synthesis.32,33 Dividing this
by the ATP turnover rate in preceding exercise (as afore-
mentioned) gives the end-exercise “fractional oxidation
rate” (the fraction of ATP produced oxidatively). It will be
seen (see “Results” section) that this is near unity and also
that pH changes (and, therefore, lactate accumulation) are
small, which independently suggest34 that the exercise is
largely oxidative.7 Oxidative ATP synthesis is a function of
three factors: mitochondrial volume and competence, oxy-
gen supply, and the metabolic “driving force” (the change
in, eg, ADP concentration33,35). The first two factors can
be lumped as the “mitochondrial capacity,” the notional
maximum oxidative ATP synthesis rate; in the absence of
large pH changes in exercise,36,37 this is conveniently
reflected by the postexercise PCr recovery rate constant
(0.693/halftime).7,35,38
Measuring oxygenation kinetics. The average rate
of NIRS fall in exercise (total NIRS change divided by
exercise duration, –∆NIRS/∆t) is an overall measure of
the rate at which oxygen supply falls short of oxygen
demand. We also calculate the maximum rate of deoxy-
genation with sequential linear regression of time-binned
NIRS data throughout exercise and express this relative to
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the rate of ATP turnover. Postexercise NIRS recovery
reflects the rate at which oxygen supply exceeds the oxy-
gen demand of recovering muscle; although unlike PCr,
NIRS recovery is not necessarily truly monoexponential,
the simplest measure is the halftime,10,18,19 conveniently
expressed as the notional rate constant (0.693/halftime).
Combining results from different exercise periods.
Results from the two 75% MVC exercise periods were not
significantly different and were combined. For brevity and
clarity, we also combined data from the 50% and 75%
MVC exercise periods wherever the physiology permits:
ATP turnover rates are derived from constrained fits of
exercise at both powers (as aforementioned). For average
rates of change during exercise and for rates of deoxy-
genation, the appropriate combination is the weighted
mean (ie, multiplying the 75% value by 50/75); for rate
constants of NIRS recovery39 and PCr recovery,36,39
which are independent of power, results at 50% and 75%
MVC are combined as a simple mean.
Assessing and reducing variability. All means of scal-
ing exercise intensity have only limited ability to reduce
intersubject variability in ATP turnover.40 The effects of
this are reduced by means of appropriate choice of data
analysis methods: exercise changes will be expressed in
terms of deviations from the resting state, corrected for
ATP turnover; recovery rate constants are, to a first
approximation, independent of end-exercise state.36,39
For variability to be measured, a coefficient of variation
(CV = SD/mean%) was calculated for each quantity mea-
sured in the three studies in each subject, and its mean
value across the group was taken as a measure of interstudy
(intrasubject) variability. The CV of mean-of-three-study
values across the group is a function of intersubject vari-
ability, but contains a contribution from purely interstudy
(intrasubject) variability. True intersubject variability was,
therefore, obtained by partioning the relative variances:
CV2INTERSUBJECT = CV2OBSERVED – (1⁄3)CV2INTERSTUDY,
in which the factor 1⁄3 allows for the effect of the triplicate
measurement in reducing the pure interstudy contribu-
tion. We also calculate the expected intersubject variability
for a single measurement as: CV2EFFECTIVE = CV2INTER-
SUBJECT + CV2INTERSTUDY.
Other statistical methods. Results are presented as
the mean ± SEM unless stated. Differences were assessed
with the Student unpaired t test, and correlations were
assessed with the Pearson correlation coefficient.
RESULTS
Resting muscle, force, and area. There were no sig-
nificant differences between patients and control subjects
in resting pH. Resting PCr/ATP and Pi/ATP were
slightly increased in patients (Table II); the simplest inter-
pretation,8 consistent with biopsy evidence,5,6 is that ATP
concentration is decreased (by 12% ± 5%), with no change
in PCr concentration.8 There were no significant differ-
ences in MVC force or muscle area or the force per unit
area (Table II).
Exercise response. Control subjects finished early in
19% of exercise periods at 50% MVC and 39% of those at
75% MVC; corresponding figures for patients were 56%
and 81%. Thus, exercise duration was significantly reduced
at both 50% and 75% MVC (Table II). Control subjects
falling short reported fatigue; patients generally reported
typical claudication. Cell pH changes during exercise were
small, being significantly nonzero only at 75% MVC (con-
trol subjects, P = .008; patients, P =.001) and significantly
different between patients and control subjects only at
50% MVC (Table II).
Both NIRS signal (Fig 1, A) and PCr (Fig 1, B) fell
during exercise, more at 75% than 50% MVC, and then
recovered. Changes were larger and recovery was slower in
patients than in control subjects, especially for NIRS.
However, the initial rate of PCr depletion (ATP turnover
rate) did not differ (Table II). Variability in force/area and
ATP turnover was quite high, but these were correlated
(control subjects, r = 0.82, P = .007; patients, r = 0.80, P
= .003), and their ratio, the contractile efficiency, was not
significantly different (Table II). Nevertheless, the overall
rate of PCr fall was larger in patients (Table II) and corre-
lated with ATP turnover (Fig 1, C); for a given ATP
turnover rate, PCr changes were larger in patients. Thus,
although ATP demand is the same, oxidative ATP pro-
duction is reduced in patients, requiring more splitting of
PCr. Consistent with this, the end-exercise fractional oxi-
dation rate (Table II) at 75% MVC was lower in patients
and significantly less than unity (P = .003).
Both the overall NIRS change and its overall rate were
increased in patients (Table II). Both correlate with ATP
turnover rate, but values are higher at given ATP turnover
in patients (shown for overall rate in Fig 1, D). Similarly,
the maximum rate of NIRS fall correlates with ATP
turnover (control subjects, r = 0.95, P = .0002; patients,
r = 0.78, P = .004), but is greater for a given ATP turnover
in patients (Table II). NIRS changes are also larger com-
pared with PCr changes in patients (∆NIRS/∆[PCr] in
Table II). Thus, measured in several ways, NIRS changes
in patients exceed what can be explained by ATP turnover.
Recovery kinetics. The recovery of PCr (Fig 2, A) and
NIRS (Fig 2, B) was slower in patients after both 50% and
75% MVC exercise; the rate constants were reduced (Table
II). Furthermore the PCr and NIRS rate constants correlate
(Fig 2, C). Finally, the NIRS rate constant correlates with
exercise duration (r = 0.84, P = .001); for PCr, the associa-
tion falls short of statistical significance (r = 0.44).
Relationships to maximum walking distance. Fig 3
shows some relationships to MWD, expressed as a recipro-
cal to fit control subjects (with “infinite” MWD) on the
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Table II. Results
Control subjects Patients with PVD P value Ratio (< 1)
Resting MRS
PCr/ATP 3.14 ± 0.09 3.38 ± 0.06 .03 0.92 ± 0.03
Pi/ATP 0.42 ± 0.03 0.50 ± 0.02 .04 0.83 ± 0.07
pH 7.027 ± 0.006 7.046 ± 0.007 .07 —
Force and area
MVC force (arbitrary) 14 ± 2 11 ± 1 .2 —
Cross-sectional area (cm2) 47 ± 2 45 ± 3 .6 —
Exercise duration (∆t)
At 50% MVC (min) 3.01 ± 0.06 2.55 ± 0.15 .01 0.83 ± 0.06
At 75% MVC (min) 2.21 ± 0.09 1.72 ± 0.11 .5 0.76 ± 0.03
Rates and fluxes in exercise 
Initial ATP turnover (1/min) 0.59 ± 0.08 0.70 ± 0.11 .9 —
Contractile efficiency (1/[min.cm2]) 0.13 ± 0.01 0.11 ± 0.01 .6 —
Mean maximum NIRS rate/ATP turnover* 12 ± 2 24 ± 3 .0003 0.46 ± 0.07
End-exercise “fractional oxidation rate”
At 50% MVC 0.90 ± 0.06 0.84 ± 0.07 .2 —
At 75% MVC 1.04 ± 0.09 0.72 ± 0.07 .003 0.69 ± 0.09
Total changes in exercise
∆pH–50% MVC 0.03 ± 0.03 0.14 ± 0.04 .03 —
∆pH–75% MVC –0.05 ± 0.01 –0.11 ± 0.03 .08 —
Mean ∆ NIRS* –7 ± 1 –14 ± 2 .01 0.48 ± 0.12
Mean ∆NIRS/∆t* (1/min) –3.5 ± 0.7 –8.1 ± 1.2 .004 0.43 ± 0.11
Mean ∆[PCr]/∆t* (1/min) –0.20 ± 0.04 –0.30 ± 0.05 .2 —
Mean ∆NIRS/∆[PCr] 19 ± 2 30 ± 2 .003 0.65 ± 0.08
Recovery
Mean NIRS rate constant (1/min) 1.02 ± 0.12 0.42 ± 0.06 .001 0.41 ± 0.07
Mean PCr rate constant (1/min) 2.08 ± 0.20 1.09 ± 0.09 .001 0.53 ± 0.07
Values are presented as mean ± SEM. Resting MRS ratios not corrected for saturation. “Mean” data are the mean of 50% MVC and 75% MVC exercise: for
quantities that are turnover- or force-dependent (*), the mean is weighted for force ratio (ie, 75:50); otherwise, they are unweighted. ATP turnover is cal-
culated simultaneously for both exercise intensities (see the “Methods” section). The P value equals the statistical significance (t test) of difference between
patients and control subjects. If P < .05, the last column shows the size of the defect as the ratio of the result in patients to that in control subjects (mean
± SEM, with standard error-propagation analysis), or vice versa, whichever gives a value less than unity (to facilitate comparison of abnormalities in variables
that increase or decrease in disease).
graph. Although there is no overall abnormality in force or
contractile efficiency (Table II), the patients who were the
clinically worst affected were the least effective at generat-
ing force (Fig 3, A) and, consequently, had lower ATP
turnover rates and PCr changes. They also had less severely
impaired PCr recovery rate constants (Fig 3, B), but there
is no significant relationship to NIRS rate constant.
Variability. The three main “outputs” of this analysis
are the contractile efficiency, the PCr recovery rate con-
stant (measures mitochondrial function), and the NIRS
recovery rate constant (measures “vascular function”).
Their interstudy CV, which measures the precision of
repeated measurements, was 12%, 17%, and 18%, respec-
tively. Population variability is conveniently measured by
means of the single-study intersubject CV (corrected for
interstudy CV), which was 30%, 37%, and 40%, respec-
tively (all CVs are expressed as the mean value for patients
and control subjects).
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DISCUSSION
Exercise protocol. This protocol has a number of
advantages. Exercise at two powers improves the chance
that changes will be large enough for precise measurement
of recovery kinetics, and the multiple-exercise element
improves precision. The dominant oxidative contribution
suits it to assessment of mitochondrial ATP synthesis in
Fig 1. MRS and NIRS changes during exercise and recovery. 
A, Mean change in NIRS signal and B, mean change in PCr con-
centration, during periods of exercise at 50% MVC and 75% MVC
(horizontal lines) and subsequent recovery are shown.
Intersubject variation has been reduced by correcting for ATP
turnover (see “Methods” section). These panels are a composite
presentation of studies in which, especially for patients, exercise
duration was often reduced; this is indicated by breaks in graphs.
C, Average rate of PCr fall and D, average rate of NIRS fall are
shown in individual subjects as function of ATP turnover rate.
Results are the mean of three different studies, and results for 75%
MVC combine two repetitions. In C and D, results are weighted
means of 50% and 75% MVC exercise (see “Methods” section).
Results are for patients (solid circles) and control subjects (open
circles). Error bars show SEM. Fig 2. NIRS and MRS postexercise recovery kinetics. A,
Fractional recovery of phosphocreatine and B, fractional recovery
of NIRS signal, as a function of recovery time after 50% MVC and
75% MVC exercise (see key), are shown. C, PCr rate is shown
constant as function of NIRS rate constant in individual subjects.
Panel also shows regression line for control subjects only (for clar-
ity), constrained through the origin. Results are the mean of three
different studies, and results for 75% MVC combine two repeti-
tions. In C, results are unweighted means of 50% and 75% MVC
exercise (see “Methods” section). Results are for patients (solid
circles and triangles) and control subjects (open circles and trian-
gles). Error bars show SEM.
A
B
C D
A
B
C
exercise,7 and the small pH changes simplify the analysis of
PCr recovery,36,37 although at the cost of making it
unsuitable for assessing acid efflux.8 Force is here scaled to
MVC.15,40 Other approaches are to scale to muscle vol-
ume40 or lean body mass8, but no approach is perfect.40
Residual force-dependence is minimized by means of
appropriate analysis.
NIRS and 31P MRS have been combined either in sep-
arate experiments10 or simultaneously with a large surface
coil with light-guides mounted laterally.39 Although both
31P MRS8,11-14,41 and NIRS17-19 have been applied in
PVD, this is the first time they have been used simultane-
ously in the same, or at least concentric, regions of inter-
est. This is especially desirable for PVD, in which muscle
blood supply may be unpredictably inhomogeneous,
depending on the vascular lesion and the development of
collaterals.
Exercise and recovery abnormalities. We found no
decrease in MVC force, in contrast to an earlier report.42
An earlier study of more severely affected patients found
an increase in ATP turnover for dynamic work, suggesting
a possible decrease in muscle mass or efficiency.23
However, with direct measurement, neither was abnormal
here. Thus, ATP demand was normal, and so the exercise
abnormalities must result from the effect of impaired oxy-
gen delivery on ATP supply. As judged by the end-exercise
fractional oxidation rate, oxidative ATP synthesis was
slightly reduced, implying a decreased functional “capac-
ity” for mitochondrial ATP synthesis, best quantified by
means of the postexercise PCr recovery rate con-
stant.7,35,37 This depends on mitochondrial volume frac-
tion,38 intrinsic mitochondrial function, and vascular
oxygen delivery. We, like others,8,14,15 found that PCr
recovery is impaired; and the simplest interpretation is that
this results directly from impaired oxygen supply.
Although the authors of a recent report15 argue that
impaired PCr recovery after 90 seconds of submaximal
isometric plantarflexion is evidence of an intrinsic mito-
chondrial defect in PVD, separable from reduced oxygen
delivery, making this inference from this study would be
unwise, in view of the substantial changes in oxygenation.
NIRS is a means of monitoring the amount of deoxy-
genated hemoglobin, which is the result of vascular oxy-
gen supply and metabolic oxygen usage. We, like
others,17-19 found that NIRS recovery is slowed in PVD,
so oxygen use outpaces delivery. Thus, oxidative metabo-
lism is impaired by reduced oxygen delivery. In support of
this, the rate constants of PCr and NIRS recovery are cor-
related (Fig 2, C), and the fractional abnormality in NIRS
recovery was larger than in PCr (Table II). (This contrasts
with chronic heart failure, in which PCr recovery is more
abnormal, because impaired oxygen use is the dominant
defect.10) During exercise, patients show greater and
faster deoxygenation during exercise, despite reduced oxy-
gen consumption (ie, oxidative ATP synthesis). The
increase in the extent of deoxygenation6 probably reflects
increased oxygen extraction, although this is inferential.
Many,8,11-14 although not all,15 MRS studies have
shown increased changes in pH and PCr during exercise in
PVD, as occurs in experimental ischemia.12,43,44 This
would be consistent with reports of increased lactate pro-
duction.4,5 The importance of this depends on the nature
of the exercise. In the substantially oxidative, isometric
exercise used here and elsewhere,15 it is at most a small
effect.
Biochemical and histologic abnormalities. Could
the defect in oxygen delivery be partially mitigated by adap-
tations such as mitochondrial proliferation? The literature
on this is confusing. There are reports of increased mito-
chondrial enzymes and protein in an experimental model45
and increased mitochondrial content46,47 and aerobic
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Fig 3. Relationships to maximum treadmill walking distance.
This figure plots values individual subjects as a function of MWD,
expressed here as a reciprocal so that control subjects (notionally
infinite MWD) can be included on same graphs. A, MVC force
(arbitrary units) expressed relative to posterior compartment
cross-sectional area. Similar relationships are seen when force is
replaced by ATP turnover, NIRS rate, or average rates of fall of
PCr and NIRS (not shown). B, Rate constant of PCr recovery
(unweighted mean of 50% MVC and 75% MVC exercise; mean of
three studies).
A
B
enzymes47-50 in patients. However, the activity of mito-
chondrial succinate oxidation is variously reported as
increased51 or decreased,52 and there are other reports of
decrease53 or no change42 in various aerobic enzymes.
Recent studies find increased mitochondrial DNA54 or no
change in mitochondrial DNA but a reduction in
cytochrome c oxidase (mitochondrially coded) relative to
citrate synthase (nuclear coded),3 with increased mitochon-
drial DNA damage, perhaps caused by oxidative stress.3
The metabolic properties of muscle are related to fiber
type, but again the literature on this is confusing. There are
reports of normal52 or increased55,56 relative abundance of
type I fibers; of reduced type IIa and increased type IIb
numbers52 or vice versa57; of reductions53 in both Type I
and II fiber area; and of reduced diameter,58 relative area,42
and numbers55,58 of type II fibers. Arguably the best guide
to functionally significant changes is the myosin heavy
chain (MHC) type: there is a relative increase in MHC I
with increasing clinical severity.2 Other things being equal,
this would increase functional mitochondrial capacity, a
potentially useful adaptation. However, even if this occurs,
the relationship between the NIRS measures of “vascular
function” and “mitochondrial capacity” (Fig 2, C) suggests
that it can only be a small effect.
Clinical and research implications. Judged by
MWD, the worse affected muscles generate less force (Fig
3, A), with consequently smaller ATP turnover and NIRS
changes during exercise; in effect, the reduced force pro-
tects them against metabolic disturbance. This may have
implications for therapy: a rehabilitation regimen that
increased force alone might worsen the consequences of
impaired oxygen delivery. Furthermore, the worse-
affected muscles have the less severe oxidative defects (Fig
3, C), perhaps because mitochondrial compensation is
more effective. Slower reoxygenation is associated with
reduced exercise duration in the scanner (see the
“Results” section). Thus, exercise on the treadmill and in
the scanner is not limited by the same factors, although
the muscle sensations are reported to be similar.
31P MRS is a more specialized and expensive tech-
nique than NIRS, but offers a more direct view of muscle
metabolism. Fig 2, C shows that the physiologic muscle
defect in PVD is well-defined by means of NIRS recovery
measurements alone,17-19 which could not necessarily
have been assumed (because of potential alterations in
contractile efficiency, and compensating effects of mito-
chondrial proliferation). However, a hypothetical treat-
ment that stimulated mitochondrial function without
improving vascular oxygen supply might further increase
muscle deoxygenation, and both methods would be
required for assessment.
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